Open AccessThymosin α1‐ and Ulinastatin‐Based Immunomodulatory Strategy for Sepsis Arising from Intra‐Abdominal Infection Due to Carbapenem‐Resistant Bacteria
Author(s) -
Ying Zhang,
Hao Chen,
Yumin Li,
Shusen Zheng,
Yagang Chen,
Lanjuan Li,
Lin Zhou,
Haiyang Xie,
Raaj Praseedom
Publication year - 2008
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/590500
Subject(s) - ulinastatin , sepsis , thymosin , carbapenem , medicine , bacteria , microbiology and biotechnology , antibiotics , biology , genetics
The aim of this study was to evaluate the potential efficacy of therapy with thymosin alpha(1) and ulinastatin for patients with sepsis due to carbapenem-resistant bacteria.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom